Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

INNOVO (Atlantic Therapeutics)

Explore full profile

The Only Clinically-Proven, Wearable, Home-Based Urinary Incontinence Treatment

Galway, IrelandFounded 2017Health Tech & Medtech
Valuation $100–250M Last recorded · 2022
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for INNOVO (Atlantic Therapeutics) and the history behind them.

About INNOVO (Atlantic Therapeutics)

Recommended by 98% of physicians and 90% of users, INNOVO is the perfect solution for treating stress urinary incontinence.

Safe, effective and FDA-cleared, INNOVO offers the only clinically-proven, wearable and truly non-invasive solution for stress urinary incontinence (SUI). Using unique multipath™ technology, INNOVO targets the weakened pelvic floor muscles, delivering 180 perfect and complete pelvic floor contractions over each 30-minute session.

Source: Dealroom company data

At a glance

Status
Acquired
Founded
2017
Headquarters
Galway, Ireland
Employees
24
Open positions
None listed
Dealroom signal
28.3/100
Industry
Health
Sub-industry
Medical Devices, Health Platform
Sector
Health Tech & Medtech, Health and Wellness, Neurology, Remote Monitoring, Non-Invasive medical devices and treatments, Spinout, Femtech, Sustainable Development Goals, Tech for Patients, Pelvic Health, Digital Care
Business model
Manufacturing

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
ACQUISITIONOther financing Sep 2023 $0 — Caldera Medical ↗
LATE VCOther financing Jan 2022 $20M $154M Undisclosed ↗
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

INNOVO (Atlantic Therapeutics) website traffic

Latest recorded traffic for INNOVO (Atlantic Therapeutics) is 500 monthly website visits, up 28.2% over the last three months. INNOVO (Atlantic Therapeutics)'s team grew 0% over the past year.

Latest monthly visits500 3-month web change+28.2% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Enterprise Ireland

Series A3 investors entered at this stage

  • EQT Life Sciences
  • Atlantic Bridge
  • Andera Partners

Series B and later4 investors entered at this stage

Other known investors2 additional known investors

  • Caldera Medical
  • University College Dublin
Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
6 countries with
team presence
🇬🇧 United Kingdom37.5%
🇪🇬 Egypt12.5%
🇦🇪 United Arab Emirates12.5%
🇮🇪 Ireland12.5%
🇫🇷 France12.5%
Top 5 of 6 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about INNOVO (Atlantic Therapeutics) on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See INNOVO (Atlantic Therapeutics)’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.